Pemetinib/Pemetinib: A closer look at price and availability

Pemigatinib is a highly potent kinase inhibitor that works by blocking the function of abnormal proteins responsible for signaling growth and reproduction to cancer cells. Therefore, pemetinib has become an important anticancer drug, especially in the treatment of certain types of cholangiocarcinoma (CCA) and myeloid/lymphoid neoplasms (MLN). However, the drug's price and availability have been a focus of concern for patients and healthcare workers.

In China, this drug has been marketed as pemetinib tablets, but due to its relatively short time on the market, it has not yet been included in the scope of medical insurance. At present, pemetinib on the domestic market mainly comes in two specifications: 4.5 mg 14 tablets and 9 mg 14 tablets, with prices ranging from RMB 30,000 to RMB 50,000. This high price undoubtedly places a heavy financial burden on patients who require long-term treatment.

At the same time, the original drug pemetinib sold in overseas markets is also expensive. Taking a drug with a specification of 13.5mg*14 tablets as an example, the price per box may be as high as about 70,000 yuan. Of course, this price will also be affected by exchange rate fluctuations. This price difference is mainly due to various factors such as drug pricing policies, taxes, and market demand in different countries and regions.

However, it is worth mentioning that there are also some generic pemetinib drugs produced by other countries on the overseas market. These generic drugs are basically the same as the original drugs in terms of drug ingredients, but there are certain differences in manufacturers, specifications and prices. For example, a pharmaceutical factory in Laos produces specifications ofThe price of 4.5mg*14 tablets of generic pemetinib may only be around RMB 1,000 per box. This price advantage allows some patients with limited financial conditions to obtain more treatment options.